Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHSE: 688076)
Health Care · Pharmaceuticals · CN
CN¥29.01
+0.28% today · -28.9% 1Y
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHSE: 688076) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.37B and employs 2,360 people.
Over the last twelve months the share price has lost 28.9%, trading between 25.70 and 41.80.
Tweenvest scores Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. across four factors: quality 62/100, value 76/100, growth 87/100, dividend 26/100. Its strongest factor is growth.
688076 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.37B
- Revenue (TTM)
- $299.46M
- P/E
- 38.51
- EPS
- 0.75
- Dividend yield
- 1.21%
- Beta (5Y)
- 0.31
- 52-week high
- CN¥41.80
- 52-week low
- CN¥25.70
- Avg volume (3M)
- —
- Shares outstanding
- 316.82M
- Employees
- 2,360
- Next earnings
- —
About Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China. The company offers Peptide CDMO Services,GMP oligo, full-time equivalent, discovery, generic APIs, and formulation services. It is also involved in professional technical services. The company was founded in 2009 and is headquartered in Hangzhou, China.
- ISIN
- CNE1000051X5
- Founded
- 2009
- Listed since
- May 20, 2021
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Omeros CorporationNasdaqGM: OMER | $1.44B | $19.89 | +0.30% |
| Nippon Shinyaku Co., Ltd.TSE: 4516 | $1.44B | ¥3,372.00 | +0.12% |
| Xiamen Kingdomway Group CompanySZSE: 002626 | $1.43B | CN¥15.89 | -1.49% |
| Zhejiang Jolly Pharmaceutical Co.,LTDSZSE: 300181 | $1.38B | CN¥13.25 | +0.30% |
| Shandong Lukang Pharmaceutical Co.,Ltd.SHSE: 600789 | $1.29B | CN¥8.28 | +5.48% |
| CORONA Remedies LimitedNSEI: CORONA | $1.28B | Rs2,024.00 | -0.27% |
| Celltrion Pharm, Inc.KOSDAQ: A068760 | $1.28B | ₩38,800.00 | -3.24% |
| Zhejiang Xianju Pharmaceutical Co., Ltd.SZSE: 002332 | $1.27B | CN¥8.76 | +1.39% |
Figures last refreshed Oct 11, 2026.